{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T09:34:59Z","timestamp":1778319299671,"version":"3.51.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-12950-3","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T06:59:58Z","timestamp":1755845998000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["TSG6 affects anti cancer drug resistance and angiogenesis in 3D spheroid model of canine mammary gland tumor cells"],"prefix":"10.1038","volume":"15","author":[{"given":"Ga-Hyun","family":"Lim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju-Hyun","family":"An","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong-Hwa","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoung-Won","family":"Seo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hwa-Young","family":"Youn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,22]]},"reference":[{"key":"12950_CR1","doi-asserted-by":"publisher","first-page":"5591","DOI":"10.1242\/jcs.116392","volume":"125","author":"FR Balkwill","year":"2012","unstructured":"Balkwill, F. R., Capasso, M. & Hagemann, T. The tumor microenvironment at a glance. J. Cell. Sci. 125, 5591\u20135596 (2012).","journal-title":"J. Cell. Sci."},{"key":"12950_CR2","doi-asserted-by":"publisher","first-page":"101985","DOI":"10.1016\/j.isci.2020.101985","volume":"24","author":"SE Shelton","year":"2020","unstructured":"Shelton, S. E., Nguyen, H. T., Barbie, D. A. & Kamm, R. D. Engineering approaches for studying immune-tumor cell interactions and immunotherapy. iScience 24, 101985 (2020).","journal-title":"iScience"},{"key":"12950_CR3","doi-asserted-by":"publisher","first-page":"153303382110363","DOI":"10.1177\/15330338211036304","volume":"20","author":"Y Li","year":"2021","unstructured":"Li, Y., Zhao, L. & Li, X. F. Hypoxia and the tumor microenvironment. Technol. Cancer Res. Treat. 20, 15330338211036304 (2021).","journal-title":"Technol. Cancer Res. Treat."},{"key":"12950_CR4","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41392-020-00280-x","volume":"5","author":"MZ Jin","year":"2020","unstructured":"Jin, M. Z. & Jin, W. L. The updated landscape of tumor microenvironment and drug repurposing. Signal. Transduct. Target. Ther. 5, 166 (2020).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"12950_CR5","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.tips.2017.05.002","volume":"38","author":"GZ Qiu","year":"2017","unstructured":"Qiu, G. Z. et al. Reprogramming of the tumor in the hypoxic niche: The emerging concept and associated therapeutic strategies. Trends Pharmacol. Sci. 38, 669\u2013686 (2017).","journal-title":"Trends Pharmacol. Sci."},{"key":"12950_CR6","doi-asserted-by":"publisher","first-page":"166","DOI":"10.5507\/bp.2015.025","volume":"159","author":"H Doktorova","year":"2015","unstructured":"Doktorova, H., Hrabeta, J., Khalil, M. A. & Eckschlager, T. Hypoxia-induced chemoresistance in cancer cells: The role of not only HIF-1. Biomed. Pap Med. Fac. Univ. Palacky Olomouc 159, 166\u2013177 (2015).","journal-title":"Biomed. Pap Med. Fac. Univ. Palacky Olomouc Czech Repub."},{"key":"12950_CR7","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.ccell.2017.10.003","volume":"32","author":"A Palazon","year":"2017","unstructured":"Palazon, A. et al. An HIF-1alpha\/VEGF-A Axis in cytotoxic T cells regulates tumor progression. Cancer Cell. 32, 669\u2013683e5 (2017).","journal-title":"Cancer Cell."},{"key":"12950_CR8","doi-asserted-by":"publisher","first-page":"46668","DOI":"10.18632\/oncotarget.8694","volume":"7","author":"D Ribatti","year":"2016","unstructured":"Ribatti, D. Tumor refractoriness to anti-VEGF therapy. Oncotarget 7, 46668\u201346677 (2016).","journal-title":"Oncotarget"},{"key":"12950_CR9","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13046-017-0570-9","volume":"36","author":"S Riffle","year":"2017","unstructured":"Riffle, S. & Hegde, R. S. Modeling tumor cell adaptations to hypoxia in multicellular tumor spheroids. J. Exp. Clin. Cancer Res. 36, 102 (2017).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"12950_CR10","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.jconrel.2012.04.045","volume":"164","author":"G Mehta","year":"2012","unstructured":"Mehta, G., Hsiao, A. Y., Ingram, M., Luker, G. D. & Takayama, S. Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy. J. Control Release  164, 192\u2013204 (2012).","journal-title":"J. Control Release"},{"key":"12950_CR11","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/jcp.20320","volume":"204","author":"S Ghosh","year":"2005","unstructured":"Ghosh, S. et al. Three-dimensional culture of melanoma cells profoundly affects gene expression profile: A high density oligonucleotide array study. J. Cell. Physiol. 204, 522\u2013531 (2005).","journal-title":"J. Cell. Physiol."},{"key":"12950_CR12","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.clon.2014.02.002","volume":"26","author":"EM Hammond","year":"2014","unstructured":"Hammond, E. M. et al. The meaning, measurement and modification of hypoxia in the laboratory and the clinic. Clin. Oncol. R. Coll. Radiol. 26, 277\u2013288 (2014).","journal-title":"Clin. Oncol. (R Coll. Radiol)"},{"key":"12950_CR13","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1158\/0008-5472.CAN-15-2818","volume":"76","author":"MW Dewhirst","year":"2016","unstructured":"Dewhirst, M. W. & Birer, S. R. Oxygen-enhanced MRI is a major advance in tumor hypoxia imaging. Cancer Res. 76, 769\u2013772 (2016).","journal-title":"Cancer Res."},{"key":"12950_CR14","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/bit.26845","volume":"116","author":"AS Nunes","year":"2019","unstructured":"Nunes, A. S., Barros, A. S., Costa, E. C., Moreira, A. F. & Correia, I. J. 3D tumor spheroids as in vitro models to mimic in vivo human solid tumors resistance to therapeutic drugs. Biotechnol. Bioeng. 116, 206\u2013226 (2019).","journal-title":"Biotechnol. Bioeng."},{"key":"12950_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jbiotec.2010.01.012","volume":"148","author":"F Hirschhaeuser","year":"2010","unstructured":"Hirschhaeuser, F. et al. Multicellular tumor spheroids: An underestimated tool is catching up again. J. Biotechnol. 148, 3\u201315 (2010).","journal-title":"J. Biotechnol."},{"key":"12950_CR16","first-page":"3015","volume":"125","author":"BM Baker","year":"2012","unstructured":"Baker, B. M. & Chen, C. S. Deconstructing the third dimension: How 3D culture microenvironments alter cellular cues. J. Cell. Sci. 125, 3015\u20133024 (2012).","journal-title":"J. Cell. Sci."},{"key":"12950_CR17","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S1359-6101(97)00008-7","volume":"8","author":"HG Wisniewski","year":"1997","unstructured":"Wisniewski, H. G. & Vilcek, J. TSG-6: An IL-1\/TNF-inducible protein with anti-inflammatory activity. Cytokine Growth Factor. Rev. 8, 143\u2013156 (1997).","journal-title":"Cytokine Growth Factor. Rev."},{"key":"12950_CR18","doi-asserted-by":"crossref","unstructured":"Day, A. J. & Milner, C. M. TSG-6: A multifunctional protein with anti-inflammatory and tissue-protective properties. Matrix Biol. 78\u201379, 60\u201383 (2019).","DOI":"10.1016\/j.matbio.2018.01.011"},{"key":"12950_CR19","doi-asserted-by":"publisher","first-page":"293e11","DOI":"10.1016\/j.urolonc.2018.12.009","volume":"37","author":"TC Chan","year":"2019","unstructured":"Chan, T. C. et al. High TNFAIP6 level is associated with poor prognosis of urothelial carcinomas. Urol. Oncol. 37, 293e11\u2013293e24 (2019).","journal-title":"Urol. Oncol."},{"key":"12950_CR20","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.7150\/ijbs.69178","volume":"18","author":"B Liu","year":"2022","unstructured":"Liu, B. et al. TSG-6 promotes Cancer cell aggressiveness in a CD44-Dependent manner and reprograms normal fibroblasts to create a Pro-metastatic microenvironment in colorectal Cancer. Int. J. Biol. Sci. 18, 1677\u20131694 (2022).","journal-title":"Int. J. Biol. Sci."},{"key":"12950_CR21","doi-asserted-by":"publisher","first-page":"5803","DOI":"10.21873\/anticanres.16087","volume":"42","author":"TH Kim","year":"2022","unstructured":"Kim, T. H. et al. Hypoxia increases the proliferative and metastatic ability of canine mammary tumor cells via up-regulation of TSG-6. Anticancer Res. 42, 5803\u20135812 (2022).","journal-title":"Anticancer Res."},{"key":"12950_CR22","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/vco.12884","volume":"21","author":"JH Lee","year":"2023","unstructured":"Lee, J. H., An, J. H. & Youn, H. Y. Tumour necrosis factor stimulated gene 6 intrinsically regulates PD-L1 expressions in breast cancer cells, leading to modulation of tumour microenvironment. Vet. Comp. Oncol. 21, 255\u2013269 (2023).","journal-title":"Vet. Comp. Oncol."},{"issue":"2","key":"12950_CR23","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/j.1476-5810.2006.00098.x","volume":"4","author":"R Uyama","year":"2006","unstructured":"Uyama, R. et al. Establishment of four pairs of canine mammary tumour cell lines derived from primary and metastatic origin and their E-cadherin expression. Vet. Comp. Oncol. 4(2), 104\u2013113 (2006).","journal-title":"Vet. Comp. Oncol."},{"key":"12950_CR24","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1292\/jvms.19-0337","volume":"81","author":"SM Kim","year":"2019","unstructured":"Kim, S. M. et al. Enhanced angiogenic activity of dimethyloxalylglycine-treated canine adipose tissue-derived mesenchymal stem cells. J. Vet. Med. Sci. 81, 1663\u20131670 (2019).","journal-title":"J. Vet. Med. Sci."},{"key":"12950_CR25","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.2337\/db13-1657","volume":"63","author":"Z Yi","year":"2014","unstructured":"Yi, Z., Stunz, L. L. & Bishop, G. A. CD40-mediated maintenance of immune homeostasis in the adipose tissue microenvironment. Diabetes 63, 2751\u20132760 (2014).","journal-title":"Diabetes"},{"key":"12950_CR26","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.3727\/096368915X689532","volume":"25","author":"M Kuk","year":"2016","unstructured":"Kuk, M., Kim, Y., Lee, S. H., Kim, W. H. & Kweon, O. K. Osteogenic ability of canine adipose-derived mesenchymal stromal cell sheets in relation to culture time. Cell. Transpl. 25, 1415\u20131422 (2016).","journal-title":"Cell. Transpl."},{"key":"12950_CR27","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.tvjl.2014.11.002","volume":"205","author":"M Zandvliet","year":"2015","unstructured":"Zandvliet, M., Teske, E., Schrickx, J. A. & Mol, J. A. A longitudinal study of ABC transporter expression in canine multicentric lymphoma. Vet. J. 205, 263\u2013271 (2015).","journal-title":"Vet. J."},{"key":"12950_CR28","doi-asserted-by":"publisher","first-page":"10394","DOI":"10.1038\/s41598-023-37311-w","volume":"13","author":"GH Lim","year":"2023","unstructured":"Lim, G. H. et al. Macrophage induces anti-cancer drug resistance in canine mammary gland tumor spheroid. Sci. Rep. 13, 10394 (2023).","journal-title":"Sci. Rep."},{"key":"12950_CR29","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1002\/hep.23597","volume":"51","author":"H Menrad","year":"2010","unstructured":"Menrad, H. et al. Roles of hypoxia-inducible factor-1alpha (HIF-1alpha) versus HIF-2alpha in the survival of hepatocellular tumor spheroids. Hepatology 51, 2183\u20132192 (2010).","journal-title":"Hepatology"},{"key":"12950_CR30","doi-asserted-by":"publisher","first-page":"e9644","DOI":"10.1371\/journal.pone.0009644","volume":"5","author":"N Pescador","year":"2010","unstructured":"Pescador, N. et al. Hypoxia promotes glycogen accumulation through hypoxia inducible factor (HIF)-mediated induction of glycogen synthase 1. PLOS ONE 5, e9644 (2010).","journal-title":"PLOS ONE"},{"key":"12950_CR31","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1186\/s12885-017-3319-0","volume":"17","author":"S Riffle","year":"2017","unstructured":"Riffle, S., Pandey, R. N., Albert, M. & Hegde, R. S. Linking hypoxia, DNA damage and proliferation in multicellular tumor spheroids. BMC Cancer 17, 338 (2017).","journal-title":"BMC Cancer"},{"key":"12950_CR32","doi-asserted-by":"crossref","unstructured":"Seo, B. R., DelNero, P. & Fischbach, C. In vitro models of tumor vessels and matrix: engineering approaches to investigate transport limitations and drug delivery in cancer. Adv. Drug Deliv. Rev. 69\u201370, 205\u2013216 (2014).","DOI":"10.1016\/j.addr.2013.11.011"},{"key":"12950_CR33","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/nature04478","volume":"438","author":"P Carmeliet","year":"2005","unstructured":"Carmeliet, P. Angiogenesis in life, disease and medicine. Nature 438, 932\u2013936 (2005).","journal-title":"Nature"},{"key":"12950_CR34","doi-asserted-by":"crossref","unstructured":"Vaupel, P. & Harrison, L. Tumor hypoxia: Causative factors, compensatory mechanisms, and cellular response. Oncologist 9, 4\u20139 (2004).","DOI":"10.1634\/theoncologist.9-90005-4"},{"key":"12950_CR35","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/28867","volume":"394","author":"P Carmeliet","year":"1998","unstructured":"Carmeliet, P. et al. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394, 485\u2013490 (1998).","journal-title":"Nature"},{"key":"12950_CR36","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1039\/c3ib40170g","volume":"6","author":"SM Ehsan","year":"2014","unstructured":"Ehsan, S. M., Welch-Reardon, K. M., Waterman, M. L., Hughes, C. C. & George, S. C. A three-dimensional in vitro model of tumor cell intravasation. Integr. Biol. 6, 603\u2013610 (2014).","journal-title":"Integr. Biol. (Camb)"},{"key":"12950_CR37","doi-asserted-by":"publisher","first-page":"594903","DOI":"10.3389\/fcell.2020.594903","volume":"8","author":"N Brassard-Jollive","year":"2020","unstructured":"Brassard-Jollive, N., Monnot, C., Muller, L. & Germain, S. Vitro 3D systems to model tumor angiogenesis and interactions with stromal cells. Front. Cell. Dev. Biol. 8, 594903 (2020).","journal-title":"Front. Cell. Dev. Biol."},{"key":"12950_CR38","doi-asserted-by":"publisher","first-page":"23890","DOI":"10.18632\/oncotarget.4341","volume":"6","author":"L Qin","year":"2015","unstructured":"Qin, L. et al. NCOA1 promotes angiogenesis in breast tumors by simultaneously enhancing both HIF1alpha- and AP-1-mediated VEGFa transcription. Oncotarget 6, 23890\u201323904 (2015).","journal-title":"Oncotarget"},{"key":"12950_CR39","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1093\/carcin\/bgs222","volume":"33","author":"S Biswas","year":"2012","unstructured":"Biswas, S. et al. CD31 angiogenesis and combined expression of HIF-1alpha and HIF-2alpha are prognostic in primary clear-cell renal cell carcinoma (CC-RCC), but HIFalpha transcriptional products are not: implications for antiangiogenic trials and HIFalpha biomarker studies in primary CC-RCC. Carcinogenesis 33, 1717\u20131725 (2012).","journal-title":"Carcinogenesis"},{"key":"12950_CR40","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1167\/iovs.13-13345","volume":"55","author":"F Mouriaux","year":"2014","unstructured":"Mouriaux, F. et al. Increased HIF-1alpha expression correlates with cell proliferation and vascular markers CD31 and VEGF-A in uveal melanoma. Invest. Ophthalmol. Vis. Sci. 55, 1277\u20131283 (2014).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"12950_CR41","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.gendis.2016.11.003","volume":"4","author":"X Lv","year":"2017","unstructured":"Lv, X. et al. The role of hypoxia-inducible factors in tumor angiogenesis and cell metabolism. Genes Dis. 4, 19\u201324 (2017).","journal-title":"Genes Dis."},{"key":"12950_CR42","doi-asserted-by":"publisher","first-page":"635","DOI":"10.3390\/biom12050635","volume":"12","author":"P Mallikarjuna","year":"2022","unstructured":"Mallikarjuna, P., Zhou, Y. & Landstr\u00f6m, M. The synergistic Cooperation between TGF-beta and hypoxia in cancer and fibrosis. Biomolecules 12, 635 (2022).","journal-title":"Biomolecules"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12950-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12950-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12950-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T19:24:59Z","timestamp":1757445899000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12950-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,22]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["12950"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-12950-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5414842\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,22]]},"assertion":[{"value":"8 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30852"}}